Grace Therapeutics (GRCE) Consolidated Net Income (2019 - 2026)
Grace Therapeutics (GRCE) posted Consolidated Net Income of -$15.79 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$3.36 million a year earlier.
Powered by 
Analysis
Grace Therapeutics (GRCE) Consolidated Net Income (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Consolidated Net Income at Grace Therapeutics was -$20.22 million; for FY2026 (ended Mar 31, 2026), it was -$7.79 million.
- In prior fiscal years, Grace Therapeutics' Consolidated Net Income was -$9.57 million in FY2025, -$12.85 million in FY2024, -$42.43 million in FY2023 and -$9.82 million in FY2022.
- The fiscal Q1 2027 figure stands as the lowest quarterly Consolidated Net Income since fiscal Q4 2023.
- According to Business Quant data, Consolidated Net Income for the three prior fiscal quarters was -$1.18 million (Q4 2026), -$2.32 million (Q3 2026) and -$938,000 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Grace Therapeutics | 33.20 Mn | 33.20 Mn | - | -15.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15.79 Mn |
| Mar 31, 2026 | -1.18 Mn |
| Dec 31, 2025 | -2.32 Mn |
| Sep 30, 2025 | -938,000.00 |
| Jun 30, 2025 | -3.36 Mn |
| Mar 31, 2025 | 636,000.00 |
| Dec 31, 2024 | -4.16 Mn |
| Sep 30, 2024 | -3.43 Mn |
| Jun 30, 2024 | -2.62 Mn |
| Mar 31, 2024 | -3.17 Mn |
| Dec 31, 2023 | -2.39 Mn |
| Sep 30, 2023 | -3.27 Mn |
| Jun 30, 2023 | -4.02 Mn |
| Mar 31, 2023 | -29.09 Mn |
| Dec 31, 2022 | -3.89 Mn |
| Sep 30, 2022 | -4.93 Mn |
| Jun 30, 2022 | -4.52 Mn |
| Mar 31, 2022 | -3.90 Mn |
| Dec 31, 2021 | -3.78 Mn |
| Sep 30, 2021 | 981,000.00 |
API Access
Grace Therapeutics Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();